Transcriptional data: a new gateway to drug repositioning?

Francesco Iorio(Open Targets), Julio Sáez-Rodríguez(European Bioinformatics Institute), Timothy Rittman(Addenbrooke's Hospital), Michael P. Menden(The University of Melbourne), Hong Ge(University of Cambridge)
Drug Discovery Today
August 6, 2012
10.1016/j.drudis.2012.07.014
Cited by 248

Related Papers

Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k
Systematic identification of genomic markers of drug sensitivity in cancer cells
|Nature|2012|2.6k
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
|Cell|2015|2.4k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
|Nature|2019|1.4k